Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Regal Partners.
RELATED STOCKHEAD STORIES
Experts
Criterion: Dividends should not be the only game when investors seek better yields
News
ASX Lunch Wrap: Stocks rally on surprise CPI rise; ETM pops 30pc on Trump’s Greenland rhetoric
Experts
Hot Money Monday: 10 ASX stocks with ‘Strong Buy’ recommendations from brokers
News
ASX Lunch Wrap: ASX starts sluggishly as iron ore, energy and ANZ take a tumble
News
ASX Small Caps Lunch Wrap: ASX up 0.8pc, job vacancies fall and Star punts on $200m bailout
News
ASX Small Caps Lunch Wrap: It’s a case of ‘hurry up and wait’ ahead of US rate call
News
Closing Bell: ASX treads water while an IPO dips on debut
IPO Watch
IPO Watch: Five of 2019’s IPO class are delivering 3x returns
IPO Watch
IPO Watch: Will 3D bone implant printing stock Osteopore overthrow 2019’s best IPO?
IPO Watch
IPO Watch: The average 2019 IPO is up 52 per cent
IPO Watch
